The lived experience of adjustment to prostate cancer.

Wilson, Gemma; Limbrick, Helen; Swainston, Katherine

doi:10.1037/men0000237

Cited by 7 publications

(4 citation statements)

References 88 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…This may be a way to gain a certain degree of control over their situation. The perception that PSA is the only sign to measure a change in disease is in line with previous research (Farrington et al, 2020) where men with localised and advanced PC regard PSA as the only indicator at their disposal and attach great importance to testing their PSA.…”

Section: Discussionsupporting

confidence: 84%

Signs and symptoms in relation to progression, experiences of an uncertain illness situation in men with metastatic castration‐resistant prostate cancer—A qualitative study

Rönningås

Holm

Doveson

et al. 2022

European J Cancer Care

View full text Add to dashboard Cite

Objective: Signs and symptoms are important in monitoring prostate cancer, but there is a lack of understanding about the men's interpretation of signs and symptoms in relation to disease progression in advanced phases of the disease. The aim was to illuminate the experience of signs and symptoms in relation to disease progression in men with metastatic castration-resistant prostate cancer (mCRPC).Method: Thirty longitudinal interviews were conducted with 11 men undergoing lifeprolonging treatment for mCRPC. Conventional content analysis was used. Results:The results illuminate an uncertainty that the men experience when interpreting signs and symptoms. The overarching theme was The experience of an uncertain illness situation within the framework of progression, with four subthemes:Symptoms triggering thoughts about disease progression; Making sense of signs, also in the absence of symptoms; Making sense of symptoms during treatment; Progression triggering thoughts about the remainder of life. Conclusion:In the uncertain illness situation, the men strive to make sense of signs and symptoms based on previous experiences and in relation to disease progression.Understanding the men's perspectives on signs and symptoms in this late phase may help health care professionals communicate about disease progression considering the balance between treatment outcome and quality of life.

show abstract

Section: Discussionsupporting

confidence: 84%

Signs and symptoms in relation to progression, experiences of an uncertain illness situation in men with metastatic castration‐resistant prostate cancer—A qualitative study

Rönningås

Holm

Doveson

et al. 2022

European J Cancer Care

View full text Add to dashboard Cite

show abstract

“…Symptoms such as pain have been described as triggering thoughts and fears about the consequences of a potential disease progression, such as being dependent on others and what dying would be like [ 29 ]. In the lack of symptoms, men with prostate cancer describe PSA-values as the only indicator they have of eventual disease progression [ 29 , 42 , 43 ]. PSA-values may therefore provoke worry and anxiety [ 26 , 44 ].…”

Section: Discussionmentioning

confidence: 99%

Symptoms and quality of life among men starting treatment for metastatic castration-resistant prostate cancer – a prospective multicenter study

Rönningås,

Holm,

Fransson

et al. 2024

BMC Palliat Care

View full text Add to dashboard Cite

Background Men with metastatic castration-resistant prostate cancer (mCRPC) have an incurable disease. Along with prolonging life, symptom management is one of the main goals with treatment. This is also important from a palliative care perspective where the life prolonging outcomes should be balanced with quality of life (QoL) in this late phase. It is also essential in symptom management to view different dimensions of symptoms, for example how severe or distressing symptoms are, to support best QoL. Therefore, more knowledge is needed about the symptom experience when these treatments are initiated and thus the aim of this study was to describe different dimensions of symptoms in men with mCRPC starting their first-line of life-prolonging treatment, and to describe the association between symptom burden and QoL. Methods Baseline data from a prospective longitudinal study of 143 men with mCRPC starting their first-line life-prolonging treatment were used. Symptoms were measured using the Memorial Symptom Assessment Scale (MSAS) and global QoL was measured by the EORTC QLQ C-30. Data was analyzed using descriptive- and multivariable linear regression analyses. Results On average, the men had more than 10 symptoms (range 0–31 of 33). 50% or more reported sweats, lack of energy, pain, problems with sexual activity and sexual desire. The symptoms they reported as most severe, or most distressing were not always the ones that were reported as most frequent. There was an association between QoL and physical symptoms, and also between QoL, and analgesic use and prostate-specific antigen (PSA) values. Conclusion Even if some men with mCRPC report many symptoms, the dimensions of severity and distress levels vary, and the most frequent symptoms was not always the most burdensome or distressing. There was an association between high physical symptom burden and QoL, suggesting that it is not the number of symptoms that affects QoL but rather the subjective perceived impact of the physical symptoms experienced. The knowledge of how men with mCRPC experience and perceive their symptoms may help health care professionals in symptom management aiming to improve QoL, which is a cornerstone in integrating early palliative care.

show abstract

“…Topics previously identified by the literature include loss of sexuality and assessment of conformity to masculine ideals affecting men with PCa's masculinity 77 ; bodily functioning affecting body image, 78 and role in the community as an advocate or mentor affecting self‐esteem 79 . These concepts are not included in current tools and would benefit from consideration in future tool generation.…”

Section: Discussionmentioning

confidence: 99%

A systematic review of tools used to assess body image, masculinity and self‐esteem in men with prostate cancer

2020

View full text Add to dashboard Cite

Objective: Masculinity, body image and self-esteem are important interlinked factors affecting prostate cancer (PCa) patients' quality of life. The aim of this systematic review was to identify and evaluate all tools measuring these domains in men with PCa. Methods: This review was conducted according to PRISMA guidelines with a priori protocol registered. Pubmed, Embase, Medline and Psychinfo were searched from inception to May 2020. Studies using a predefined tool which measured any body image, self-esteem or masculinity construct in men with PCa were included, as well as validation studies of these. Reliability, validity and responsiveness of tools identified were objectively evaluated against the COSMIN taxonomy of measurement properties. Results: From 1416 records screened, a final 46 studies consisting of 17 different tools were included in the systematic review. Seven tools were identified assessing body image, nine masculinity and one self-esteem, varying widely in their number of items, possible responses and domains assessed. Most tools had evaluated internal consistency through Cronbach's alpha analysis; however, structural and discriminative validity, and responsiveness were lacking for many. Additionally, only one tool identified was specifically developed and evaluated in patients with PCa: The Masculinity in Chronic Disease Inventory. Conclusions: Numerous tools have been used for the measurement of body image, masculinity and self-esteem in men with PCa. However, few were developed specifically for these patients. More research is therefore needed to ascertain specific factors affecting these outcomes in PCa patients, so valid, reliable and clinically relevant tools can be developed.

show abstract

The lived experience of adjustment to prostate cancer.

Cited by 7 publications

References 88 publications

Signs and symptoms in relation to progression, experiences of an uncertain illness situation in men with metastatic castration‐resistant prostate cancer—A qualitative study

Signs and symptoms in relation to progression, experiences of an uncertain illness situation in men with metastatic castration‐resistant prostate cancer—A qualitative study

Symptoms and quality of life among men starting treatment for metastatic castration-resistant prostate cancer – a prospective multicenter study

A systematic review of tools used to assess body image, masculinity and self‐esteem in men with prostate cancer

Contact Info

Product

Resources

About